TPSi launches pharma opinion leaders panel

The FutureThinker Panel is made up of 1,000 influential clinicians from the US, the UK, Germany, France, Italy and Spain, selected using a psycho-profiling tool developed by the firm.

The firm said it is working with one of the largest pharmaceutical database suppliers to expand the panel.

TPSi managing director Kim Hughes said: “The FutureThinker Panel is an exciting initiative that will allow pharmaceutical companies to develop strategy and prioritise tactics based on the feedback of these highly influential opinion formers.”